1

Akili

#9765

Rank

$34.1M

Marketcap

US United States

Country

Akili
Leadership team

Dr. Walter Edward Martucci Ph.D. (Co-Founder, CEO & Director)

Dr. Adam Gazzaley M.D., Ph.D. (Co-founder, Chief Science Advisor & Director)

Mr. Santosh Shanbhag (CFO & Treasurer)

Products/ Services
Biotechnology, Health Care, Medical, Neuroscience, Service Industry, Therapeutics
Number of Employees
100 - 500
Headquarters
Boston, Massachusetts, United States
Established
2011
Company Registration
SEC CIK number: 0001850266
Net Income
2M - 5M
Traded as
AKLI
Social Media
Overview
Location
Summary
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
History

Akili was founded by Eddie Martucci, an entrepreneur with a previous executive experience in game technology, and Adam Gazzaley, an academic neuroscientist at University of California San Francisco, in 2016. Initially, Akili partnered with Pfizer and Shire to develop a digital medicine for ADHD, which was tested published findings in JAMA Pediatrics in 2017 and was granted treatment investigational device exemption (IDE) by United States Food and Drug Administration (FDA).

Mission
The mission of Akili is to develop and deliver digital therapeutics designed to improve the lives of people with neuro-behavioral disorders.
Vision
Our vision is to create transformational technologies that offer better health outcomes and make evidence-based treatments accessible and affordable for everyone around the world.
Key Team

Ms. Jacqueline L. Studer J.D. (Chief Legal Officer, Gen. Counsel & Sec.)

Ms. Barrie Brian (Sr. VP of People)

Mr. Matthew Franklin M.B.A. (Pres & COO)

Mr. Matthew Omernick (Co-Founder & Chief Creative Officer)

Dr. Scott H. Kollins Ph.D. (Chief Medical Officer)

Mr. Carl Gottlieb (Chief Technology Officer)

Ms. Julie DiCarlo (Sr. VP of Communications)

Recognition and Awards
Akili has won two awards- The EY Global Emerging Entrepreneur of the Year Award in 2018 and The Webby Awards People's Voice in 2019.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Akili
Leadership team

Dr. Walter Edward Martucci Ph.D. (Co-Founder, CEO & Director)

Dr. Adam Gazzaley M.D., Ph.D. (Co-founder, Chief Science Advisor & Director)

Mr. Santosh Shanbhag (CFO & Treasurer)

Products/ Services
Biotechnology, Health Care, Medical, Neuroscience, Service Industry, Therapeutics
Number of Employees
100 - 500
Headquarters
Boston, Massachusetts, United States
Established
2011
Company Registration
SEC CIK number: 0001850266
Net Income
2M - 5M
Traded as
AKLI
Social Media